Zinc-binding proteins (metallothionein and α-2 macroglobulin) as potential biological markers of immunosenescence

NeuroImmune Biology

Volumn 4, Issue C, 2004, Pages 23-40

  Mocchegiani, Eugenio ^a   Giacconi, Robertina ^a   Muti, Elisa ^a   Muzzioli, Mario ^a   Cipriano, Catia ^a  

^a INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957781442     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(04)80004-8     Document Type: Chapter

References (100)

1. Wellinghausen N., Kirchner H., and Rink L. The immunobiology of zinc. Immunol Today 18 (1997) 519-521
2. Mocchegiani E., Muzzioli M., Cipriano C., and Giacconi R. Zinc, T-cell pathways, ageing: role of metallothioneins. Mech Ageing Dev 106 (1998) 183-204
3. Dardenne M., Pleau J.M., Nabarra B., Lefrancier P., Derrien M., Choay J., and Bach J.F. Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc Natl Acad Sci USA 79 (1982) 5370-5373
4. Hadden J.W. Thymic endocrinology. Ann NY Acad Sci 840 (1998) 352-358
5. Mocchegiani E., Verbanac D., Santarelli L., Tibaldi A., Muzzioli M., Radosevic-Stasic B., and Milin C. Zinc and metallothioneins on cellular immune effectiveness during liver regenration, in young and old mice. Life Sci 61 (1997) 1125-1145
6. Abo T., Kawamura T., and Watanabe H. Physiological responses of extrathymic T cells in the liver. Immunol Rev 174 (2000) 135-149
7. Kagi J.H., and Schaffer A. Biochemistry of metallothionein. Biochemistry 27 23 (1988 Nov 15) 8509-8515
8. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 6 (1992) 3345-3353
9. Kelly E.J., Quaife C.J., Froelick G.J., and Palmiter R.D. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J Nutr 126 (1996) 1782-1790
10. Coto J.A., Hadden E.M., Sauro M., Zorn N., and Hadden J.W. Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on, T-lymphocyte proliferation and nuclear protein kinase C. Proc Natl Acad Sci USA 89 (1992) 7752-7756
11. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Moresi R., Stecconi R., Suzuki H., Cavalieri E., and Mariani E. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp Gerontol 37 (2002) 349-357
12. Rink L., and Seyfarth M. Characteristics of immunologic test values in the elderly. Z Gerontol Geriatr 30 (1997) 220-225
13. Mocchegiani E., Muzzioli M., and Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol Sci 21 (2000) 205-208
14. Mocchegiani E., Giacconi R., Cipriano C., Gasparini N., Orlando F., Stecconi R., Muzzioli M., Isani G., and Carpene. Metallothioneins (I+II) and thyroid-thymus axis efficiency in old mice: role of corticosterone and zinc supply. Mech Ageing Dev 123 (2002) 675-694
15. Shankar A.H., and Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 68 (1998) 447S-463S
16. In: Mills C.F. (Ed). Zinc in human biology (1989), Springer Verlag, London 1-600
17. Vallee B.L., and Falchuk K.H. The biochemical basis of zinc physiology. Physiol Rev 73 (1993) 79-118
18. Lowther W.T., and Matthews B.W. Metalloaminopeptidases: common functional themes in disparate structural surroundings. Chem Rev 102 (2002) 4581-4608
19. Coleman J.E. Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem 61 (1992) 897-946
20. Taylor G.A., and Blackshear P.J. Zinc inhibits turnover of labile mRNAs in intact cells. J Cell Physiol 162 (1995) 378-387
21. In: Hopper N.L. (Ed). Zinc and metalloproteases in health and disease (1996), Taylor and Francis, London 1-750
22. Kolkenbrock H., Orgel D., Hecker-Kia A., Noack W., and Ulbrich N. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur J Biochem 198 (1991) 775-781
23. Sottrup-Jensen L. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem 264 (1989) 11539-11542
24. Miyazaki K., Funahashi K., Numata Y., Koshikawa N., Akaogi K., Kikkawa Y., Yasumitsu H., and Umeda M. Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low molecular weight TIMP-like protein. J Biol Chem 268 (1993) 14387-14393
25. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 31 (1999 Jul 30) 21491-21494
26. Stetler-Stevenson W.G., Liotta L.A., and Kleiner Jr. D.E. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7 15 (1993 Dec) 1434-1441
27. Ashcroft G.S., Herrick S.E., Tarnuzzer R.W., Horan M.A., Schultz G.S., and Ferguson M.W. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and-2 proteins and mRNA. J Pathol 183 (1997) 169-176
28. Ebadi M., and Swanson S. The status of zinc, copper, and metallothionein in cancer patients. Prog Clin Biol Res 259 (1988) 161-175
29. Matoska J., Wahlstrom T., Vaheri A., Bizik J., and Grofova M. Tumor-associated alpha-2-macroglobulin in human melanomas. Int J Cancer 41 (1988) 359-363
30. Maret W., and Vallee B.L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci USA 95 (1998) 3478-3482
31. West A.K., Stallings R., Hildebrand C.E., Chiu R., Karin M., and Richards R.I. Human metallothionein genes: structure of the functional locus at 16q13. Genomics 8 (1990) 513-518
32. Otvos J.D., Engeseth H.R., Nettesheim D.G., and Hilt C.R. Interprotein metal exchange reactions of metallothionein. Experientia Suppl 52 (1987) 171-178
33. Lazo J.S., Kuo S.M., Woo E.S., and Pitt B.R. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs. Chem Biol Interact 111-112 (1998) 255-262
34. Palmiter R.D. Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1. Proc Natl Acad Sci USA 91 (1994) 1219-1223
35. Cai L., Satoh M., Tohyama C., and Cherian M.G. Metallothionein in radiation exposure: its induction and protective role. Toxicology 132 (1999) 85-98
36. Ashok B.T., and Ali R. The aging paradox: free radical theory of aging. Exp Gerontol 34 (1999) 293-303
37. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Fattoretti P., Bertoni-Freddari C., Isani G., Zambenedetti P., and Zatta P. Zinc-bound metallothioneins as potential biological markers of ageing. Brain Res Bull 55 (2001) 147-153
38. Mocchegiani E., Muzzioli M., Giacconi R., Cipriano C., Gasparini N., Franceschi C., Gaetti R., Cavalieri E., and Suzuki H. Metallothioneins/PARP-I/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev 124 (2003) 459-468
39. Zambenedetti P., Giordano R., and Zatta P. Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease. J Chem Neuroanat 15 (1998) 21-26
40. Abdel-Mageed A., and Agrawal K.C. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther 4 (1997) 199-207
41. Sandstead H.H. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr 61 3 Suppl (1995) 621S-624S
42. Starkey P.M., and Barrett A.J. Evolution of alpha 2-macroglobulin. The demonstration in a variety of vertebrate species of a protein resembling human alpha 2-macroglobulin. Biochem J 205 (1982) 91-95
43. Chu C.T., Howard G.C., Misra U.K., and Pizzo S.V. Alpha 2-macroglobulin: a sensor for proteolysis. Ann N Y Acad Sci 737 (1994) 291-307
44. Strickland D.K., Ashcom J.D., Williams S., Burgess W.H., Migliorini M., and Argraves W.S. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem 265 (1990) 17401-17404
45. Williams S.E., Ashcom J.D., Argraves W.S., and Strickland D.K. A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. J Biol Chem 267 (1992) 9035-9040
46. Gliemann J., Nykjaer A., Petersen C.M., Jorgensen K.E., Nielsen M., Andreasen P.A., Christensen E.I., Lookene A., Olivecrona G., and Moestrup S.K. The multiligand alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP). Binding and endocytosis of fluid phase and membrane-associated ligands. Ann N Y Acad Sci 737 (1994) 20-38
47. Gottschall P.E., and Deb S. Regulation of matrix metalloproteinase expressions in astrocytes, microglia, and neurons. Neuroimmunomodulation 3 (1996) 69-75
48. Mocchegiani E., Ciavattini A., Santarelli L., Tibaldi A., Muzzioli M., Bonazzi P., Giacconi R., Fabris N., and Garzetti G.G. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma. Br J Cancer 79 (1999) 244-250
49. Krauskopf A., and Blackburn E.H. Control of telomere growth by interactions of RAP1 with the most distal telomeric repeats. Nature 383 (1996) 354-357
50. Shore D. Telomeric chromatin: replicating and wrapping up chromosome ends. Curr Opin Genet Dev 11 (2001) 189-198
51. Kveiborg M., Kassem M., Langdahl B., Eriksen E.F., Clark B.F., and Rattan S.I. Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive, telomere loss in osteoporotic patients. Mech Ageing Dev 106 (1999) 261-271
52. Marcand S., Gilson E., and Shore D. A protein-counting mechanism for telomere length regulation in yeast. Science 275 (1997) 986-990
53. Van Leuven F., Thiry E., Stas L., and Nelissen B. Analysis of the human LRPAP1 gene coding for the lipoprotein receptor-associated protein: identification of 22 polymorphisms and one mutation. Genomics 52 (1998) 145-151
54. Mocchegiani E., Muzzioli M., Gaetti R., Veccia S., Viticchi C., and Scalise G. Contribution of zinc to reduce CD4+risk factor for 'severe' infection relapse in aging: parallelism with HIV. Int J Immunopharmacol 21 (1999) 271-281
55. Tissot C., and Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 270 (1995) 14891-14898
56. Papageorgiou A.C., Collins C.M., Gutman D.M., Kline J.B., O'Brien S.M., Tranter H.S., and Acharya K.R. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors. EMBO J 18 (1999) 9-21
57. Turnlund J.R., Durkin N., Costa F., and Margen S. Stable isotope studies of zinc absorption and retention in young and elderly men. J Nutr 116 (1986) 1239-1247
58. Mocchegiani E., Santarelli L., Muzzioli M., and Fabris N. Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice. Int J Immunopharmacol 17 (1995) 703-718
59. Cakman I., Rohwer J., Schutz R.M., Kirchner H., and Rink L. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech Ageing Dev 87 (1996) 197-209
60. Franceschi C., Bonafe M., and Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 18 (2000) 1717-1720
61. Franceschi C., and Bonafe M. Centenarians as a model for healthy aging. Biochem Soc Trans 31 (2003) 457-461
62. Muzzioli M., Mocchegiani E., Bressani N., Bevilacqua P., and Fabris N. In vitro restoration by thymulin of NK activity of cells from old mice. Int J Immunopharmacol 14 (1992) 57-61
63. Trinchieri G. Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Semin Immunol 7 (1995) 83-88
64. Tanaka Y., Shiozawa S., Morimoto I., and Fujita T. Role of zinc in interleukin 2 (IL-2)-mediated T-cell activation. Scand J Immunol 31 (1990) 547-552
65. Saha A.R., Hadden E.M., and Hadden J.W. Zinc induces thymulin secretion from human thymic epithelial cells in vitro and augments splenocyte and thymocyte responses in vivo. Int J Immunopharmacol 17 (1995) 729-733
66. Ohteki T., Okuyama R., Seki S., Abo T., Sugiura K., Kusumi A., Ohmori T., Watanabe H., and Kumagai K. Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J Immunol 149 (1992 Sep 1) 1562-1570
67. Cui L., Takagi Y., Wasa M., Iiboshi Y., Inoue M., Khan J., Sando K., Nezu R., and Okada A. Zinc deficiency enhances interleukin-1alpha-induced metallothionein-1 expression in rats. J Nutr 128 (1998) 1092-1098
68. Bui L.M., Dressendorfer R.H., Keen C.L., Summary J.J., and Dubick M.A. Zinc status and interleukin-1 beta-induced alterations in mineral metabolism in rats. Proc Soc Exp Biol Med 206 (1994) 438-444
69. Yu C.W., Chen J.H., and Lin L.Y. Metal-induced metallothionein gene expression can be inactivated by protein kinase C inhibitor. FEBS Lett 420 (1997) 69-73
70. Penkowa M., Giralt M., Moos T., Thomsen P.S., Hernandez J., and Hidalgo J. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice. Exp Neurol 156 (1999) 149-164
71. Deng D.X., Cai L., Chakrabarti S., and Cherian M.G. Increased radiation-induced apoptosis in mouse thymus in the absence of metallothionein. Toxicology 134 (1999) 39-49
72. Johnston C.J., Finkelstein J.N., Gelein R., and Oberdorster G. Pulmonary cytokine and chemokine mRNA levels after inhalation of lipopolysaccharide in C57BL/6 mice. Toxicol Sci 46 (1998) 300-307
73. Miller G.G., and Strittmatter W.J. Identification of human T cells that require zinc for growth. Scand J Immunol 36 (1992) 269-277
74. Zangger K., Oz G., Haslinger E., Kunert O., and Armitage I.M. Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at inflammatory sites. FASEB J 15 (2001) 1303-1305
75. Kroncke K.D. Zinc finger proteins as molecular targets for nitric oxide-mediated gene regulation. Antioxid Redox Signal 3 (2001) 565-575
76. Lysiak J.J., Hussaini I.M., and Gonias S.L. alpha 2-Macroglobulin synthesis by the human monocytic cell line THP-1 is differentiation state-dependent. J Cell Biochem 67 (1997) 492-497
77. Heumann D., and Vischer T.L. Immunomodulation by alpha 2-macroglobulin and alpha 2-macroglobulin-proteinase complexes: the effect on the human T lymphocyte response. Eur J Immunol 18 (1988) 755-760
78. Hoffman M.R., Pizzo S.V., and Weinberg J.B. Modulation of mouse peritoneal macrophage Ia and human peritoneal macrophage HLA-DR expression by alpha 2-macroglobulin "fast" forms. J Immunol 139 (1987) 1885-1890
79. Borth W. Alpha 2-macroglobulin. A multifunctional binding and targeting protein with possible roles in immunity and autoimmunity. Ann N Y Acad Sci 737 (1994) 267-272
80. Kahari V.M., and Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 31 (1999) 34-45
81. James K. Interactions between cytokines and alpha 2-macroglobulin. Immunol Today 11 (1990) 163-166
82. Gonias S.L., LaMarre J., Crookston K.P., Webb D.J., Wolf B.B., Lopes M.B., Moses H.L., and Hayes M.A. Alpha 2-macroglobulin and the alpha 2-macroglobulin receptor/LRP. A growth regulatory axis. Ann N Y Acad Sci 737 (1994) 273-290
83. Dinarello C.A. Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism. Int J Tissue React 14 (1992) 65-75
84. Horn F., Wegenka U.M., Lutticken C., Yuan J., Roeb E., Boers W., Buschmann J., and Heinrich P.C. Regulation of alpha 2-macroglobulin gene expression by interleukin-6. Ann N Y Acad Sci 737 (1994) 308-323
85. Gettins P.G., and Crews B.C. Binding of epidermal growth factor to human alpha 2-macroglobulin. Significance for cytokine alpha 2-macroglobulin interactions. Ann N Y Acad Sci 737 (1994) 383-398
86. Diehl S., and Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39 (2002) 531-536
87. Frasca D., Pucci S., Goso C., Barattini P., Barile S., Pioli C., and Doria G. Regulation of cytokine production in aging: use of recombinant cytokines to upregulate mitogen-stimulated spleen cells. Mech Ageing Dev 93 (1997) 157-169
88. Iwata T., Incefy G.S., Tanaka T., Fernandes G., Menendez-Botet C.J., Pih K., and Good R.A. Circulating thymic hormone levels in zinc deficiency. Cell Immunol 47 (1979) 100-105
89. Dardenne M., Boukaiba N., Gagnerault M.C., Homo-Delarche F., Chappuis P., Lemonnier D., and Savino W. Restoration of the thymus in aging mice by in vivo zinc supplementation. Clin Immunol Immunopathol 66 (1993) 127-135
90. Provinciali M., Di Stefano G., and Stronati S. Flow cytometric analysis of CD3/TCR complex, zinc, and glucocorticoid-mediated regulation of apoptosis and cell cycle distribution in thymocytes from old mice. Cytometry 32 (1998) 1-8
91. Barbieri D., Troiano L., Grassilli E., Agnesini C., Cristofalo E.A., Monti D., Capri M., Cossarizza A., and Franceschi C. Inhibition of apoptosis by zinc: a reappraisal. Biochem Biophys Res Commun 187 (1992) 1256-1261
92. Liang J.Y., Liu Y.Y., Zou J., Franklin R.B., Costello L.C., and Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 40 (1999) 200-207
93. Xu J., Xu Y., Nguyen Q., Novikoff P.M., and Czaja M.J. Induction of hepatoma cell apoptosis by c-myc requires zinc and occurs in the absence of DNA fragmentation. Am J Physiol 270 (1996) G60-G70
94. Prasad A.S., Fitzgerald J.T., Hess J.W., Kaplan J., Pelen F., and Dardenne M. Zinc deficiency in elderly patients. Nutrition 9 (1993) 218-224
95. Boukaiba N., Flament C., Acher S., Chappuis P., Piau A., Fusselier M., Dardenne M., and Lemonnier D. A physiological amount of zinc supplementation: effects of nutritional, lipid, and thymic status in an elderly population. Am J Clin Nutr 57 (1993) 566-572
96. Bogden J.D., Oleske J.M., Lavenhar M.A., Munves E.M., Kemp F.W., Bruening K.S., Holding K.J., Denny T.N., Guarino M.A., and Holland B.K. Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly. J Am Coll Nutr 9 (1990) 214-225
97. Fabris N., Mocchegiani E., and Albertini A. Psycoendocrine-immune interactions in Down's syndrome: role of zinc. In: Castell S., and Wisnieski K.E. (Eds). Growth hormone treatment in Down's syndrome (1994), John Wiley and Sons, New York 203-218
98. Chiricolo M., Musa A.R., Monti D., Zannotti M., and Franceschi C. Enhanced DNA repair in lymphocytes of Down syndrome patients: the influence of zinc nutritional supplementation. Mutat Res 295 (1993) 105-111
99. Franceschi C., Valensin S., Fagnoni F., Barbi C., and Bonafe M. Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp Gerontol 34 (1999) 911-921
100. Kovacs D.M. alpha2-macroglobulin in late-onset Alzheimer's disease. Exp Gerontol 35 (2000) 473-479